Common Stock, Shares, Outstanding of Lineage Cell Therapeutics, Inc. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lineage Cell Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • Lineage Cell Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 243,121,801, a 10% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Lineage Cell Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 243,121,801 +22,705,475 +10% 31 Dec 2025 10-K 05 Mar 2026 2025 FY
Q3 2025 230,327,537 +41,490,162 +22% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 228,356,290 +39,532,315 +21% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 228,356,290 +39,602,754 +21% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 220,416,326 +45,429,655 +26% 31 Dec 2024 10-K 05 Mar 2026 2025 FY
Q3 2024 188,837,375 +13,850,704 +7.9% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 188,823,975 +14,384,541 +8.2% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 188,753,536 +18,579,747 +11% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 174,986,671 +4,893,557 +2.9% 31 Dec 2023 10-K 10 Mar 2025 2024 FY
Q3 2023 174,986,671 +5,100,336 +3% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 174,439,434 +4,690,941 +2.8% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 170,173,789 +446,394 +0.26% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 170,093,114 +615,767 +0.36% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 169,886,335 +1,421,335 +0.84% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 169,748,493 +2,711,982 +1.6% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 169,727,395 +7,660,498 +4.7% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 169,477,347 +16,381,464 +11% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 168,465,000 +18,473,546 +12% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 167,036,511 +17,205,164 +11% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 162,066,897 +12,248,897 +8.2% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 153,095,883 +3,291,599 +2.2% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 149,991,454 +201,454 +0.13% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 149,831,347 +188,347 +0.13% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 149,818,000 +430,000 +0.29% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 149,804,284 +22,668,284 +18% 31 Dec 2019 10-K 11 Mar 2021 2020 FY
Q3 2019 149,790,000 +22,906,000 +18% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 149,643,000 +22,770,000 +18% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 149,388,000 +22,519,000 +18% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 127,136,000 +270,000 +0.21% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 126,884,000 +11,079,960 +9.6% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 126,873,000 +15,997,390 +14% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 126,869,000 +16,009,000 +14% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 126,866,000 +24,090,000 +23% 31 Dec 2017 10-K 14 Mar 2019 2018 FY
Q3 2017 115,804,040 +13,032,040 +13% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 110,875,610 +9,207,610 +9.1% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 110,860,000 +20,439,000 +23% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 102,776,000 +12,354,446 +14% 31 Dec 2016 10-K 15 Mar 2018 2017 FY
Q3 2016 102,772,000 +20,727,000 +25% 30 Sep 2016 10-Q 04 Nov 2016 2016 Q3
Q2 2016 101,668,000 +23,281,000 +30% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 90,421,000 +12,104,167 +15% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 90,421,554 +12,193,798 +16% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q3 2015 82,045,000 +13,753,240 +20% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 78,387,000 +11,517,016 +17% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 78,316,833 +19,245,641 +33% 31 Mar 2015 10-Q 08 May 2015 2015 Q1
Q4 2014 78,227,756 +21,513,332 +38% 31 Dec 2014 10-K 15 Mar 2016 2015 FY
Q3 2014 68,291,760 +12,668,826 +23% 30 Sep 2014 10-Q 07 Nov 2014 2014 Q3
Q2 2014 66,869,984 +11,253,050 +20% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 59,071,192 +6,519,379 +12% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 56,714,424 +7,331,215 +15% 31 Dec 2013 10-K 11 Mar 2015 2014 FY
Q3 2013 55,622,934 +6,460,176 +13% 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 55,616,934 +6,112,717 +12% 30 Jun 2013 10-Q 09 Aug 2013 2013 Q2
Q1 2013 52,551,813 +3,516,025 +7.2% 31 Mar 2013 10-Q 10 May 2013 2013 Q1
Q4 2012 49,383,209 +347,421 +0.71% 31 Dec 2012 10-K 17 Mar 2014 2013 FY
Q3 2012 49,162,758 +210,523 +0.43% 30 Sep 2012 10-Q 09 Nov 2012 2012 Q3
Q2 2012 49,504,217 +634,894 +1.3% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 49,035,788 31 Mar 2012 10-Q 10 May 2012 2012 Q1
Q4 2011 49,035,788 +1,258,087 +2.6% 31 Dec 2011 10-K 18 Mar 2013 2012 FY
Q3 2011 48,952,235 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 48,869,323 30 Jun 2011 10-Q 09 Aug 2011 2011 Q2
Q4 2010 47,777,701 31 Dec 2010 10-K 14 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.